HYDROXYCHLOROQUINE

HYDROXYCHLOROQUINE was reported 91640 times

HYDROXYCHLOROQUINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 445 0.6662
1 RHEUMATOID FACTOR NEGATIVE 103 0.5886
2 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 177 0.5268
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 1044 0.5212
4 SWOLLEN JOINT COUNT INCREASED 1608 0.5038
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3594 0.5011
6 RHEUMATIC FEVER 2223 0.4982
7 LUPUS VULGARIS 605 0.4802
8 RHEUMATOID FACTOR POSITIVE 2733 0.4727
9 GRIP STRENGTH 103 0.4498
10 DUODENAL ULCER PERFORATION 3343 0.4491
11 C-REACTIVE PROTEIN 412 0.4444
12 FACET JOINT SYNDROME 1431 0.4391
13 C-REACTIVE PROTEIN ABNORMAL 2788 0.4342
14 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 997 0.4324
15 SWOLLEN JOINT COUNT 104 0.4160
16 X-RAY ABNORMAL 721 0.4028
17 PEMPHIGUS 4846 0.3872
18 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 801 0.3862
19 RENAL PHOSPHOLIPIDOSIS 52 0.3824
20 SYNOVITIS 6872 0.3807
21 CENTRAL NERVOUS SYSTEM LUPUS 80 0.3587
22 HAND DEFORMITY 4594 0.3499
23 DISLOCATION OF VERTEBRA 797 0.3491
24 GRANULOMA SKIN 280 0.3410
25 JOINT LAXITY 102 0.3377
26 MUSCLE INJURY 2787 0.3360
27 TRUNCUS ARTERIOSUS PERSISTENT 65 0.3266
28 HELICOBACTER INFECTION 3359 0.3265
29 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 182 0.3244
30 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2097 0.3226
31 RETINITIS 548 0.3169
32 ANTICIPATORY ANXIETY 86 0.3162
33 FOLLICULITIS 3084 0.2938
34 BODY HEIGHT BELOW NORMAL 188 0.2924
35 SERONEGATIVE ARTHRITIS 333 0.2906
36 RED BLOOD CELL SEDIMENTATION RATE 76 0.2724
37 BONE EROSION 940 0.2655
38 PERIPHERAL VENOUS DISEASE 1057 0.2586
39 PRESBYACUSIS 78 0.2532
40 INTESTINAL SEPSIS 66 0.2519
41 BLOOD IRON ABNORMAL 241 0.2467
42 RETINAL TOXICITY 253 0.2456
43 PERICARDITIS 3837 0.2281
44 DRUG TOLERANCE DECREASED 635 0.2259
45 LOOSE BODY IN JOINT 60 0.2256
46 BLOOD PARATHYROID HORMONE DECREASED 326 0.2198
47 CONTRAINDICATED PRODUCT ADMINISTERED 6608 0.2180
48 GLOSSODYNIA 4579 0.2043
49 RHEUMATOID NODULE 551 0.1999
50 ANKLE ARTHROPLASTY 71 0.1956
51 HYPOCHOLESTEROLAEMIA 67 0.1898
52 LUPUS NEPHRITIS 338 0.1806
53 ONYCHOMADESIS 751 0.1788
54 OVERLAP SYNDROME 124 0.1771
55 BREAST CANCER STAGE III 1144 0.1765
56 JOINT DESTRUCTION 273 0.1754
57 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1930 0.1743
58 GRIP STRENGTH DECREASED 1512 0.1716
59 SYSTEMIC LUPUS ERYTHEMATOSUS 6012 0.1692
60 RHEUMATOID LUNG 160 0.1675
61 NECK DEFORMITY 71 0.1599
62 PORPHYRIA ACUTE 223 0.1554
63 EPIDURAL LIPOMATOSIS 53 0.1541
64 WRIST DEFORMITY 94 0.1528
65 JOINT RANGE OF MOTION DECREASED 2012 0.1499
66 PANNICULITIS 360 0.1486
67 LIP DRY 1321 0.1453
68 IRRITABLE BOWEL SYNDROME 3106 0.1447
69 ONYCHOMYCOSIS 629 0.1432
70 WOUND 3938 0.1407
71 ELBOW DEFORMITY 48 0.1387
72 TENOSYNOVITIS 380 0.1376
73 HYPERCHOLESTEROLAEMIA 1330 0.1376
74 SYNOVIAL DISORDER 59 0.1297
75 BURSITIS 1558 0.1283
76 NAIL OPERATION 51 0.1232
77 LIVE BIRTH 1030 0.1230
78 ENTHESOPATHY 192 0.1227
79 FIBROMYALGIA 2981 0.1225
80 WOUND INFECTION 1293 0.1180
81 RHEUMATOID ARTHRITIS 13209 0.1162
82 AUTOIMMUNE DISORDER 1132 0.1160
83 DEAFNESS TRANSITORY 96 0.1124
84 BUTTERFLY RASH 113 0.1114
85 THERAPEUTIC PRODUCT EFFECT DECREASED 4881 0.1089
86 ARTHROPATHY 6000 0.1078
87 FINGER DEFORMITY 518 0.1068
88 DEATH NEONATAL 143 0.1027
89 JUVENILE IDIOPATHIC ARTHRITIS 251 0.1025
90 BLEPHAROSPASM 636 0.1009
91 JOINT ANKYLOSIS 57 0.1004
92 IMPAIRED HEALING 3255 0.0990
93 DRUG INTOLERANCE 9382 0.0970
94 POLYARTHRITIS 508 0.0963
95 BONE CYST 89 0.0949
96 LIVER INJURY 2285 0.0930
97 ANTIBODY TEST POSITIVE 154 0.0927
98 SCIATICA 1473 0.0923
99 OBESITY 1458 0.0914
100 PULMONARY FIBROSIS 1746 0.0909
101 JOINT ARTHROPLASTY 160 0.0893
102 NAIL DISORDER 780 0.0891
103 C-REACTIVE PROTEIN INCREASED 3239 0.0889
104 PLEURAL FIBROSIS 89 0.0873
105 LARYNGEAL DISORDER 63 0.0873
106 PSORIATIC ARTHROPATHY 3485 0.0858
107 PLEURAL THICKENING 57 0.0833
108 BLOOD PRESSURE DIASTOLIC ABNORMAL 210 0.0825
109 FOOT DEFORMITY 899 0.0810
110 RETINOPATHY 292 0.0782
111 MATERNAL EXPOSURE TIMING UNSPECIFIED 294 0.0782
112 TYPE 2 DIABETES MELLITUS 2612 0.0775
113 LOWER RESPIRATORY TRACT INFECTION 3527 0.0775
114 TREATMENT FAILURE 6235 0.0752
115 EXOSTOSIS 683 0.0747
116 LUPUS-LIKE SYNDROME 662 0.0729
117 INFUSION SITE REACTION 218 0.0729
118 JOINT SWELLING 8720 0.0722
119 HEPATIC ENZYME INCREASED 4911 0.0720
120 ARTHRODESIS 73 0.0717
121 WALKING AID USER 472 0.0715
122 CARDIAC SEPTAL DEFECT 51 0.0709
123 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 125 0.0702
124 BONE SWELLING 67 0.0692
125 CONGENITAL CARDIOVASCULAR ANOMALY 58 0.0691
126 INFUSION RELATED REACTION 4584 0.0691
127 HIP ARTHROPLASTY 1059 0.0691
128 PUSTULAR PSORIASIS 234 0.0681
129 SOFT TISSUE DISORDER 74 0.0667
130 BLOOD PRESSURE SYSTOLIC ABNORMAL 160 0.0647
131 BACK INJURY 680 0.0625
132 LIMB DEFORMITY 98 0.0616
133 DRUG TOLERANCE 312 0.0616
134 OSTEOARTHRITIS 2607 0.0614
135 BLOOD MAGNESIUM INCREASED 55 0.0610
136 PRODUCT LABEL CONFUSION 354 0.0607
137 DRUG SPECIFIC ANTIBODY 83 0.0606
138 SKIN NECROSIS 311 0.0599
139 MACULOPATHY 210 0.0591
140 LOWER LIMB FRACTURE 1132 0.0589
141 SWELLING 5452 0.0582
142 KNEE ARTHROPLASTY 1218 0.0578
143 BLISTER 3246 0.0577
144 BLOOD CHOLESTEROL INCREASED 2693 0.0577
145 INFECTION REACTIVATION 66 0.0576
146 ALLERGY TO CHEMICALS 71 0.0570
147 GAIT INABILITY 1903 0.0569
148 COELIAC DISEASE 548 0.0558
149 APPARENT DEATH 201 0.0558
150 STOMATITIS 3379 0.0557
151 NIGHT SWEATS 1783 0.0553
152 ALANINE AMINOTRANSFERASE ABNORMAL 116 0.0550
153 DISCOMFORT 3354 0.0549
154 OCULAR TOXICITY 60 0.0543
155 SPONDYLITIS 196 0.0538
156 PRESCRIBED OVERDOSE 1040 0.0537
157 HISTOPLASMOSIS DISSEMINATED 85 0.0535
158 MUSCULOSKELETAL STIFFNESS 4648 0.0530
159 WHEELCHAIR USER 235 0.0528
160 JOINT DISLOCATION 553 0.0523
161 MOBILITY DECREASED 3745 0.0521
162 LIVER FUNCTION TEST INCREASED 1114 0.0518
163 INFLAMMATION 2636 0.0510
164 BREAST CANCER STAGE II 421 0.0506
165 DERMATOMYOSITIS 127 0.0501
166 DACTYLITIS 49 0.0499
167 PRESCRIBED UNDERDOSE 984 0.0493
168 ORAL MUCOSAL EXFOLIATION 74 0.0489
169 PNEUMONIA VIRAL 153 0.0479
170 ANTIPHOSPHOLIPID SYNDROME 77 0.0479
171 CONGENITAL ANOMALY 364 0.0470
172 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2241 0.0466
173 OSTEOPOROTIC FRACTURE 88 0.0459
174 ULCER HAEMORRHAGE 311 0.0459
175 RASH VESICULAR 220 0.0455
176 ILL-DEFINED DISORDER 2757 0.0453
177 FINE MOTOR SKILL DYSFUNCTION 131 0.0452
178 MUSCLE SPASTICITY 554 0.0450
179 EAR PAIN 872 0.0448
180 JOINT STIFFNESS 1176 0.0448
181 CUTANEOUS LUPUS ERYTHEMATOSUS 87 0.0447
182 MATERNAL EXPOSURE DURING PREGNANCY 3963 0.0444
183 SHOULDER ARTHROPLASTY 118 0.0438
184 JOINT EFFUSION 299 0.0433
185 SYNOVIAL CYST 196 0.0424
186 MUSCULOSKELETAL PAIN 2215 0.0422
187 LOW BIRTH WEIGHT BABY 326 0.0410
188 NORMAL NEWBORN 223 0.0410
189 GASTROINTESTINAL DISORDER 3616 0.0403
190 HEPATIC CIRRHOSIS 757 0.0402
191 RETINAL DEGENERATION 52 0.0400
192 PULMONARY TOXICITY 283 0.0400
193 CUSHINGOID 126 0.0392
194 INVESTIGATION ABNORMAL 56 0.0389
195 PLEURITIC PAIN 107 0.0387
196 THERAPY NON-RESPONDER 1719 0.0382
197 CENTRAL NERVOUS SYSTEM LYMPHOMA 52 0.0377
198 ADRENAL INSUFFICIENCY 458 0.0377
199 EYE INJURY 114 0.0375
200 PERIPHERAL SWELLING 5701 0.0370
201 ABDOMINAL DISCOMFORT 6065 0.0361
202 SINUSITIS 3693 0.0360
203 INTENTIONAL PRODUCT USE ISSUE 3155 0.0360
204 VIRAL UPPER RESPIRATORY TRACT INFECTION 171 0.0359
205 HEPATITIS 915 0.0357
206 INJURY 2476 0.0352
207 FIBROSIS 108 0.0351
208 EXPOSURE DURING PREGNANCY 2181 0.0351
209 NODULE 454 0.0348
210 ADVERSE REACTION 461 0.0347
211 COLITIS MICROSCOPIC 164 0.0346
212 OSTEOSCLEROSIS 54 0.0343
213 SPINAL FUSION SURGERY 138 0.0340
214 SLEEP DISORDER 2387 0.0338
215 LIVER DISORDER 1492 0.0336
216 DISABILITY 658 0.0332
217 NOCARDIOSIS 85 0.0332
218 NECK MASS 94 0.0332
219 SCLERITIS 53 0.0331
220 LUNG DISORDER 1614 0.0329
221 VARICELLA ZOSTER VIRUS INFECTION 68 0.0328
222 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2333 0.0328
223 CUTANEOUS VASCULITIS 119 0.0326
224 SPINAL STENOSIS 134 0.0324
225 DRUG-INDUCED LIVER INJURY 1018 0.0324
226 WHEEZING 1900 0.0320
227 TUBERCULIN TEST POSITIVE 81 0.0320
228 FOOT OPERATION 157 0.0317
229 RESPIRATORY DISORDER 946 0.0316
230 NEOPLASM SKIN 49 0.0315
231 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 537 0.0313
232 CREPITATIONS 93 0.0312
233 THYROID NEOPLASM 86 0.0312
234 ALOPECIA 6109 0.0311
235 INFECTION 4484 0.0309
236 BODY TEMPERATURE INCREASED 630 0.0308
237 ROAD TRAFFIC ACCIDENT 1291 0.0308
238 CYSTOID MACULAR OEDEMA 58 0.0308
239 RHEUMATIC DISORDER 59 0.0305
240 ANTINUCLEAR ANTIBODY POSITIVE 99 0.0304
241 FOETAL GROWTH RESTRICTION 183 0.0301
242 HYPERCALCAEMIA 370 0.0299
243 DEAFNESS NEUROSENSORY 98 0.0298
244 OEDEMA 1616 0.0298
245 BASAL CELL CARCINOMA 463 0.0296
246 OSTEOPOROSIS 1219 0.0296
247 MYOSITIS 265 0.0295
248 ARTHRITIS 2314 0.0294
249 GASTROINTESTINAL TOXICITY 141 0.0293
250 SENSITIVITY TO WEATHER CHANGE 154 0.0292
251 INTESTINAL POLYP 48 0.0292
252 GENERAL PHYSICAL HEALTH DETERIORATION 3377 0.0292
253 LATENT TUBERCULOSIS 61 0.0291
254 TASTE DISORDER 585 0.0288
255 COVID-19 PNEUMONIA 340 0.0288
256 CONTUSION 2731 0.0283
257 ARTHRITIS BACTERIAL 115 0.0280
258 HEPATIC FIBROSIS 96 0.0279
259 IMMUNODEFICIENCY 415 0.0278
260 HYPERSENSITIVITY 5162 0.0278
261 METHAEMOGLOBINAEMIA 64 0.0276
262 ULCER 439 0.0276
263 JOINT INJURY 587 0.0275
264 JOINT LOCK 78 0.0274
265 DELIRIUM 946 0.0272
266 INFLAMMATORY MARKER INCREASED 130 0.0262
267 DEFORMITY 244 0.0261
268 BREATH SOUNDS ABNORMAL 128 0.0259
269 LOSS OF EMPLOYMENT 78 0.0258
270 EAR INFECTION 685 0.0257
271 ELECTROCARDIOGRAM QT PROLONGED 922 0.0256
272 PREGNANCY 512 0.0255
273 IMMOBILE 111 0.0254
274 GENERAL SYMPTOM 190 0.0253
275 DRUG ERUPTION 449 0.0253
276 JOINT NOISE 49 0.0249
277 HEPATIC ENZYME ABNORMAL 124 0.0248
278 EPIGASTRIC DISCOMFORT 96 0.0246
279 PREMATURE DELIVERY 386 0.0242
280 EPILEPSY 737 0.0241
281 CONDITION AGGRAVATED 7262 0.0239
282 GRANULOMA 81 0.0234
283 NASOPHARYNGITIS 4257 0.0231
284 SKIN ULCER 595 0.0230
285 HEPATIC STEATOSIS 428 0.0230
286 ARTHRALGIA 9543 0.0229
287 DIVERTICULITIS 635 0.0229
288 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 114 0.0222
289 HYPOGAMMAGLOBULINAEMIA 146 0.0222
290 CHONDROPATHY 60 0.0221
291 DRY MOUTH 1783 0.0220
292 SKIN PAPILLOMA 88 0.0219
293 MYOPATHY 189 0.0219
294 MUSCULOSKELETAL DISORDER 408 0.0214
295 BONE DENSITY ABNORMAL 78 0.0209
296 HERPES ZOSTER 1186 0.0206
297 TENDERNESS 215 0.0206
298 CARDIOTOXICITY 183 0.0205
299 DRUG USE DISORDER 172 0.0204
300 TERMINAL STATE 136 0.0203
301 PRODUCT USE ISSUE 3817 0.0203
302 CONFUSIONAL STATE 3282 0.0203
303 BACK DISORDER 330 0.0203
304 NECK PAIN 1133 0.0203
305 FUNCTIONAL GASTROINTESTINAL DISORDER 70 0.0202
306 IMPAIRED WORK ABILITY 432 0.0202
307 PREMATURE BABY 606 0.0201
308 BLOOD PRESSURE SYSTOLIC INCREASED 392 0.0201
309 HEPATOTOXICITY 446 0.0200
310 DYSPEPSIA 1946 0.0198
311 URTICARIA 3292 0.0196
312 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 147 0.0196
313 VASCULITIS 223 0.0191
314 CARDIOMYOPATHY 281 0.0190
315 BRAIN ABSCESS 48 0.0189
316 HYPERTENSION 4004 0.0189
317 FOOD INTOLERANCE 69 0.0188
318 HYPERTRANSAMINASAEMIA 131 0.0188
319 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 50 0.0188
320 TORSADE DE POINTES 147 0.0187
321 DISSEMINATED TUBERCULOSIS 48 0.0187
322 MOUTH ULCERATION 392 0.0186
323 HEPATITIS B REACTIVATION 58 0.0183
324 HYPOAESTHESIA 2720 0.0182
325 SUSPECTED OFF LABEL USE 82 0.0181
326 KERATITIS 55 0.0181
327 THERAPEUTIC RESPONSE DECREASED 1092 0.0180
328 OFF LABEL USE 15732 0.0179
329 PRE-ECLAMPSIA 85 0.0179
330 WEIGHT INCREASED 3959 0.0177
331 PNEUMATOSIS INTESTINALIS 50 0.0175
332 DYSLIPIDAEMIA 89 0.0175
333 RASH 7638 0.0175
334 PULMONARY THROMBOSIS 191 0.0175
335 PAIN 10713 0.0174
336 BLOOD PRESSURE DIASTOLIC DECREASED 127 0.0172
337 INTERSTITIAL LUNG DISEASE 831 0.0171
338 BLOOD PRESSURE DIASTOLIC INCREASED 79 0.0171
339 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 939 0.0171
340 BRONCHOPULMONARY ASPERGILLOSIS 132 0.0170
341 PROTEIN URINE PRESENT 84 0.0168
342 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 130 0.0167
343 PULMONARY MASS 249 0.0167
344 PHARYNGITIS 207 0.0167
345 PULMONARY TUBERCULOSIS 71 0.0166
346 MIGRAINE 1520 0.0159
347 TRIGGER FINGER 65 0.0159
348 THERAPY PARTIAL RESPONDER 248 0.0159
349 DRUG INEFFECTIVE 20918 0.0159
350 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 79 0.0158
351 FEAR OF INJECTION 113 0.0158
352 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 130 0.0157
353 UPPER RESPIRATORY TRACT INFECTION 719 0.0155
354 SEPTIC SHOCK 670 0.0154
355 ADVERSE EVENT 1415 0.0153
356 FOETAL EXPOSURE DURING PREGNANCY 1245 0.0153
357 LYME DISEASE 51 0.0153
358 ABDOMINAL PAIN UPPER 3148 0.0153
359 LEUKOPENIA 760 0.0152
360 ACUTE RESPIRATORY DISTRESS SYNDROME 266 0.0150
361 HEART DISEASE CONGENITAL 53 0.0150
362 TONGUE DISORDER 108 0.0149
363 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 252 0.0148
364 SKIN REACTION 209 0.0148
365 NEONATAL RESPIRATORY DISTRESS SYNDROME 52 0.0147
366 MULTIPLE ALLERGIES 115 0.0147
367 BLOOD PRESSURE FLUCTUATION 352 0.0147
368 ONYCHOCLASIS 100 0.0145
369 MUSCULAR WEAKNESS 1636 0.0144
370 VISUAL FIELD DEFECT 104 0.0144
371 CARPAL TUNNEL SYNDROME 201 0.0143
372 NEPHROPATHY 133 0.0142
373 AMNESIA 926 0.0142
374 GLAUCOMA 274 0.0142
375 GASTROINTESTINAL PAIN 156 0.0142
376 ASPERGILLUS INFECTION 93 0.0142
377 PAIN IN EXTREMITY 4166 0.0141
378 WEIGHT FLUCTUATION 147 0.0140
379 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 134 0.0140
380 HYPERKERATOSIS 77 0.0139
381 ENCEPHALITIS 96 0.0139
382 SKIN LACERATION 150 0.0138
383 ADVERSE DRUG REACTION 1238 0.0138
384 OVERWEIGHT 74 0.0138
385 FEMUR FRACTURE 426 0.0137
386 PRODUCT USE IN UNAPPROVED INDICATION 3404 0.0137
387 OSTEOPENIA 208 0.0137
388 RASH PRURITIC 742 0.0137
389 LYMPHOPENIA 192 0.0136
390 BODY TEMPERATURE DECREASED 133 0.0135
391 FOETAL DEATH 70 0.0135
392 TENDON DISORDER 88 0.0135
393 SKIN MASS 90 0.0135
394 VENTRICULAR SEPTAL DEFECT 77 0.0134
395 ORAL DISORDER 98 0.0134
396 GASTROENTERITIS VIRAL 241 0.0133
397 OSTEOMYELITIS 241 0.0133
398 PROTEINURIA 253 0.0133
399 HERPES SIMPLEX 86 0.0132
400 HYPOCALCAEMIA 250 0.0132
401 DRUG SPECIFIC ANTIBODY PRESENT 85 0.0131
402 MATERNAL EXPOSURE DURING BREAST FEEDING 53 0.0131
403 SARCOIDOSIS 62 0.0130
404 PHOTOSENSITIVITY REACTION 215 0.0130
405 RED CELL DISTRIBUTION WIDTH INCREASED 54 0.0130
406 ASTHMA 1468 0.0130
407 ESCHERICHIA URINARY TRACT INFECTION 55 0.0129
408 ARTHRITIS INFECTIVE 60 0.0129
409 MATERNAL EXPOSURE BEFORE PREGNANCY 88 0.0129
410 INTERVERTEBRAL DISC DEGENERATION 119 0.0128
411 CORONAVIRUS INFECTION 85 0.0128
412 ATRIOVENTRICULAR BLOCK COMPLETE 86 0.0128
413 GAIT DISTURBANCE 2453 0.0128
414 INJECTION SITE REACTION 877 0.0127
415 GASTROOESOPHAGEAL REFLUX DISEASE 1019 0.0126
416 BONE DENSITY DECREASED 396 0.0126
417 IMMUNOSUPPRESSION 111 0.0126
418 SECRETION DISCHARGE 157 0.0125
419 IMMUNE SYSTEM DISORDER 165 0.0125
420 POST PROCEDURAL INFECTION 101 0.0124
421 ROTATOR CUFF SYNDROME 159 0.0124
422 BONE DISORDER 225 0.0123
423 THYROID DISORDER 190 0.0123
424 HYPOKALAEMIA 568 0.0123
425 PNEUMONIA 3981 0.0123
426 SPINAL OSTEOARTHRITIS 108 0.0123
427 PYREXIA 4245 0.0123
428 IRON DEFICIENCY 55 0.0122
429 LYMPHOMA 189 0.0122
430 RASH MACULO-PAPULAR 272 0.0122
431 TYPE 1 DIABETES MELLITUS 73 0.0121
432 LIMB DISCOMFORT 375 0.0121
433 SUBCUTANEOUS ABSCESS 58 0.0121
434 LIMB OPERATION 58 0.0121
435 CANDIDA INFECTION 204 0.0121
436 LEFT VENTRICULAR HYPERTROPHY 51 0.0119
437 DERMATITIS ALLERGIC 149 0.0118
438 LOCALISED INFECTION 286 0.0118
439 FATIGUE 9207 0.0118
440 MEDICATION ERROR 650 0.0117
441 PNEUMOCYSTIS JIROVECII PNEUMONIA 117 0.0116
442 PLEURISY 69 0.0116
443 CYST 144 0.0116
444 MEMORY IMPAIRMENT 1590 0.0116
445 INSOMNIA 3080 0.0116
446 UVEITIS 156 0.0115
447 BRONCHITIS 848 0.0114
448 PURPURA 101 0.0114
449 EYE DISORDER 375 0.0114
450 TOOTH INFECTION 150 0.0114
451 REBOUND EFFECT 128 0.0113
452 ORAL CANDIDIASIS 149 0.0113
453 PHYSICAL DISABILITY 50 0.0113
454 MULTIPLE ORGAN DYSFUNCTION SYNDROME 320 0.0113
455 MENINGITIS 75 0.0112
456 ORAL DISCOMFORT 154 0.0111
457 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 285 0.0111
458 EPSTEIN-BARR VIRUS INFECTION 69 0.0110
459 ALANINE AMINOTRANSFERASE INCREASED 678 0.0110
460 FREQUENT BOWEL MOVEMENTS 298 0.0110
461 OEDEMA PERIPHERAL 1343 0.0110
462 CHEST PAIN 2035 0.0110
463 ANKYLOSING SPONDYLITIS 144 0.0109
464 INTERVERTEBRAL DISC PROTRUSION 237 0.0108
465 PRURITUS 4158 0.0108
466 MASS 150 0.0107
467 NERVE COMPRESSION 98 0.0106
468 SKIN LESION 288 0.0105
469 GASTROINTESTINAL INFECTION 94 0.0105
470 IMMUNE THROMBOCYTOPENIA 48 0.0105
471 DIFFUSE LARGE B-CELL LYMPHOMA 80 0.0104
472 DECREASED APPETITE 2398 0.0103
473 CATARACT 614 0.0103
474 ABSCESS 164 0.0103
475 DYSSTASIA 300 0.0103
476 ANAPHYLACTIC REACTION 567 0.0103
477 PSEUDOMONAS INFECTION 88 0.0103
478 ASPARTATE AMINOTRANSFERASE INCREASED 543 0.0102
479 VOMITING 4777 0.0102
480 PNEUMOTHORAX 161 0.0101
481 DRUG EFFECT INCOMPLETE 366 0.0101
482 TENDONITIS 156 0.0101
483 PYELONEPHRITIS 87 0.0100
484 ABORTION INDUCED 94 0.0100
485 PULMONARY ALVEOLAR HAEMORRHAGE 56 0.0100
486 BLOOD IRON DECREASED 118 0.0099
487 COVID-19 1742 0.0099
488 MENISCUS INJURY 61 0.0099
489 INJECTION SITE INFLAMMATION 49 0.0098
490 PARAESTHESIA 1545 0.0098
491 APHTHOUS ULCER 76 0.0098
492 VEIN DISORDER 49 0.0098
493 POSTOPERATIVE WOUND INFECTION 66 0.0098
494 QUALITY OF LIFE DECREASED 131 0.0098
495 HEADACHE 6120 0.0098
496 PAIN IN JAW 276 0.0097
497 LIVER FUNCTION TEST ABNORMAL 282 0.0097
498 GASTRIC DISORDER 331 0.0096
499 HAEMATOCRIT DECREASED 191 0.0096
500 ATELECTASIS 92 0.0095
501 PNEUMONIA BACTERIAL 87 0.0095
502 RALES 55 0.0095
503 MALAISE 4151 0.0095
504 ASTHENIA 3558 0.0095
505 VENTRICULAR TACHYCARDIA 156 0.0094
506 DEPRESSION 2145 0.0094
507 ACUTE RESPIRATORY FAILURE 181 0.0094
508 TONSILLITIS 49 0.0094
509 SKIN PLAQUE 79 0.0094
510 PSORIASIS 1220 0.0093
511 SPINAL DISORDER 88 0.0093
512 RESPIRATORY TRACT INFECTION 242 0.0093
513 LABORATORY TEST ABNORMAL 273 0.0092
514 ABNORMAL LOSS OF WEIGHT 63 0.0092
515 TOOTH ABSCESS 93 0.0091
516 MUSCULOSKELETAL DISCOMFORT 157 0.0091
517 UROSEPSIS 84 0.0091
518 DRY EYE 454 0.0091
519 FOOT FRACTURE 172 0.0091
520 ORAL PAIN 203 0.0091
521 SKIN INFECTION 101 0.0090
522 ESCHERICHIA INFECTION 74 0.0090
523 RENAL CYST 71 0.0089
524 TOXIC EPIDERMAL NECROLYSIS 135 0.0089
525 DISEASE RECURRENCE 420 0.0088
526 DIARRHOEA 5673 0.0088
527 CARDIAC MURMUR 76 0.0088
528 TRANSAMINASES INCREASED 195 0.0088
529 MUSCLE SPASMS 1590 0.0087
530 NAUSEA 6847 0.0086
531 BRONCHIECTASIS 58 0.0086
532 STENT PLACEMENT 69 0.0085
533 SYMPTOM RECURRENCE 51 0.0085
534 TENDON RUPTURE 105 0.0085
535 MULTIPLE FRACTURES 139 0.0085
536 MALIGNANT MELANOMA 113 0.0084
537 POOR VENOUS ACCESS 87 0.0084
538 COLITIS ULCERATIVE 374 0.0084
539 DYSPNOEA 4729 0.0083
540 WEIGHT DECREASED 2328 0.0083
541 HEART RATE DECREASED 292 0.0083
542 VISUAL IMPAIRMENT 1028 0.0083
543 SKIN HYPERPIGMENTATION 71 0.0083
544 IRON DEFICIENCY ANAEMIA 76 0.0082
545 OXYGEN SATURATION DECREASED 462 0.0082
546 ODYNOPHAGIA 49 0.0082
547 RECTAL HAEMORRHAGE 351 0.0082
548 GASTROENTERITIS 119 0.0081
549 ANKLE FRACTURE 126 0.0081
550 LIMB INJURY 221 0.0081
551 BACTERAEMIA 96 0.0081
552 RED BLOOD CELL COUNT DECREASED 231 0.0081
553 MOVEMENT DISORDER 259 0.0081
554 FEEDING DISORDER 163 0.0080
555 VITAMIN D DEFICIENCY 78 0.0080
556 BACTERIAL INFECTION 149 0.0080
557 SQUAMOUS CELL CARCINOMA 75 0.0080
558 SPINAL PAIN 93 0.0079
559 HAEMOLYTIC ANAEMIA 71 0.0079
560 RESPIRATORY RATE INCREASED 70 0.0079
561 ABDOMINAL PAIN 1828 0.0078
562 BLOOD CREATININE INCREASED 513 0.0078
563 PANCYTOPENIA 438 0.0078
564 PLEURAL EFFUSION 476 0.0078
565 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 229 0.0078
566 TOOTH FRACTURE 86 0.0078
567 PRODUCTIVE COUGH 371 0.0078
568 HAEMOLYSIS 60 0.0078
569 HERNIA 150 0.0077
570 SCOLIOSIS 48 0.0077
571 RESPIRATORY FAILURE 561 0.0077
572 DEAFNESS 201 0.0077
573 LIGAMENT SPRAIN 76 0.0077
574 WHITE BLOOD CELL COUNT INCREASED 294 0.0077
575 INJECTION SITE EXTRAVASATION 94 0.0076
576 RESPIRATORY DEPRESSION 93 0.0076
577 LYMPHOEDEMA 52 0.0075
578 BACK PAIN 1746 0.0075
579 PNEUMONITIS 204 0.0075
580 UNDERDOSE 545 0.0075
581 LEFT VENTRICULAR DYSFUNCTION 50 0.0075
582 PHARYNGEAL SWELLING 73 0.0075
583 RENAL TUBULAR NECROSIS 73 0.0074
584 DECREASED IMMUNE RESPONSIVENESS 73 0.0074
585 ORAL HERPES 144 0.0074
586 WRIST FRACTURE 88 0.0073
587 CYSTITIS 233 0.0073
588 BLOOD ALBUMIN DECREASED 58 0.0073
589 CYTOMEGALOVIRUS INFECTION 121 0.0073
590 DERMATITIS 152 0.0072
591 FLUID RETENTION 366 0.0072
592 CYTOPENIA 88 0.0072
593 MUSCULOSKELETAL CHEST PAIN 111 0.0072
594 HYPOTHYROIDISM 229 0.0072
595 NEOPLASM MALIGNANT 474 0.0071
596 HYPOKINESIA 103 0.0071
597 EOSINOPHILIA 124 0.0071
598 BLOOD PRESSURE INCREASED 1073 0.0070
599 ATRIOVENTRICULAR BLOCK 54 0.0070
600 STAPHYLOCOCCAL INFECTION 230 0.0070
601 MACULAR DEGENERATION 83 0.0069
602 DRUG INTERACTION 1101 0.0069
603 POST PROCEDURAL COMPLICATION 133 0.0069
604 DIZZINESS 3450 0.0069
605 LUNG INFILTRATION 61 0.0069
606 RIB FRACTURE 142 0.0069
607 SPUTUM DISCOLOURED 65 0.0068
608 FEELING HOT 420 0.0068
609 BLOOD URINE PRESENT 130 0.0068
610 PERICARDIAL EFFUSION 158 0.0068
611 SARS-COV-2 TEST POSITIVE 90 0.0068
612 DEEP VEIN THROMBOSIS 442 0.0068
613 ABDOMINAL DISTENSION 709 0.0068
614 DERMATITIS BULLOUS 49 0.0068
615 SPLENOMEGALY 79 0.0067
616 FLANK PAIN 63 0.0067
617 NEURALGIA 163 0.0067
618 TACHYCARDIA 593 0.0067
619 PULMONARY HYPERTENSION 139 0.0067
620 BODY HEIGHT DECREASED 71 0.0066
621 SEPSIS 734 0.0066
622 CONJUNCTIVITIS 122 0.0066
623 RHINORRHOEA 425 0.0066
624 HAEMOGLOBIN DECREASED 669 0.0065
625 TOOTH DISORDER 144 0.0065
626 FALL 2155 0.0065
627 GENERALISED OEDEMA 80 0.0065
628 MUCOSAL INFLAMMATION 169 0.0064
629 ERYTHEMA MULTIFORME 60 0.0064
630 RESPIRATORY TRACT CONGESTION 102 0.0064
631 INCREASED TENDENCY TO BRUISE 59 0.0064
632 BLOOD TEST ABNORMAL 90 0.0064
633 BEDRIDDEN 84 0.0064
634 INTENTIONAL DOSE OMISSION 182 0.0064
635 FOOD ALLERGY 49 0.0063
636 TREATMENT NONCOMPLIANCE 347 0.0063
637 MITRAL VALVE INCOMPETENCE 71 0.0063
638 LYMPHADENOPATHY 221 0.0062
639 DRUG EFFECT DECREASED 335 0.0062
640 TOXICITY TO VARIOUS AGENTS 1048 0.0062
641 VENTRICULAR FIBRILLATION 69 0.0062
642 DYSPNOEA EXERTIONAL 233 0.0062
643 OROPHARYNGEAL PAIN 571 0.0062
644 CARDIOGENIC SHOCK 88 0.0061
645 MYOCARDITIS 70 0.0061
646 INFLUENZA 679 0.0061
647 SKIN DISORDER 202 0.0061
648 NEPHROLITHIASIS 277 0.0060
649 DIABETES MELLITUS 459 0.0060
650 ATRIAL FLUTTER 48 0.0060
651 HYSTERECTOMY 52 0.0060
652 FACIAL PARALYSIS 51 0.0060
653 RENAL IMPAIRMENT 501 0.0060
654 NEUTROPHIL COUNT INCREASED 61 0.0060
655 PHOTOPHOBIA 112 0.0059
656 HYPOPHAGIA 152 0.0059
657 CELLULITIS 299 0.0059
658 TOOTHACHE 107 0.0059
659 SPINAL OPERATION 72 0.0058
660 SPINAL FRACTURE 117 0.0058
661 DRUG RESISTANCE 149 0.0058
662 MOTOR DYSFUNCTION 59 0.0058
663 URINARY TRACT INFECTION 987 0.0058
664 THROMBOSIS 465 0.0058
665 IMPAIRED QUALITY OF LIFE 83 0.0058
666 EYE INFECTION 65 0.0058
667 PANCREATITIS 304 0.0057
668 COUGH 1600 0.0057
669 GROIN PAIN 50 0.0057
670 DRUG LEVEL INCREASED 94 0.0057
671 THROMBOCYTOPENIA 635 0.0057
672 KIDNEY INFECTION 111 0.0057
673 GINGIVAL BLEEDING 77 0.0056
674 PRODUCT PRESCRIBING ERROR 134 0.0056
675 CARDIOMEGALY 68 0.0055
676 INTESTINAL PERFORATION 62 0.0055
677 LOSS OF CONSCIOUSNESS 707 0.0055
678 ACUTE KIDNEY INJURY 840 0.0055
679 VENTRICULAR EXTRASYSTOLES 57 0.0055
680 HYPERTENSIVE CRISIS 61 0.0055
681 WHITE BLOOD CELL COUNT DECREASED 593 0.0055
682 SLEEP APNOEA SYNDROME 104 0.0054
683 ANXIETY 1547 0.0054
684 PULMONARY EMBOLISM 515 0.0054
685 EMPHYSEMA 54 0.0053
686 POLYNEUROPATHY 64 0.0053
687 MIDDLE INSOMNIA 98 0.0052
688 DENTAL CARIES 58 0.0052
689 PLATELET COUNT INCREASED 68 0.0052
690 PSYCHOTIC DISORDER 154 0.0052
691 NASAL CONGESTION 306 0.0052
692 SINUS CONGESTION 70 0.0052
693 HIATUS HERNIA 67 0.0052
694 PHARYNGITIS STREPTOCOCCAL 56 0.0052
695 SCAR 88 0.0051
696 VIRAL INFECTION 171 0.0051
697 OVARIAN CYST 51 0.0051
698 LUNG INFECTION 79 0.0051
699 ILLNESS 517 0.0050
700 RENAL FAILURE 662 0.0050
701 FUNGAL INFECTION 166 0.0050
702 OSTEONECROSIS 163 0.0050
703 SINUS TACHYCARDIA 70 0.0049
704 PERITONITIS 102 0.0049
705 UPPER LIMB FRACTURE 98 0.0049
706 NEPHROPATHY TOXIC 55 0.0049
707 HYPERLIPIDAEMIA 58 0.0048
708 ENCEPHALOPATHY 119 0.0048
709 HYPOTENSION 969 0.0048
710 SHOCK 111 0.0048
711 BLOOD POTASSIUM INCREASED 78 0.0048
712 MYELODYSPLASTIC SYNDROME 69 0.0048
713 OESOPHAGITIS 52 0.0048
714 LEUKOCYTOSIS 86 0.0047
715 SEASONAL ALLERGY 67 0.0047
716 ANGIOEDEMA 209 0.0047
717 HYPOXIA 166 0.0047
718 RESPIRATORY DISTRESS 130 0.0047
719 NEUROPATHY PERIPHERAL 447 0.0047
720 EATING DISORDER 100 0.0047
721 ABORTION SPONTANEOUS 188 0.0047
722 HEART RATE INCREASED 464 0.0047
723 PHARYNGEAL OEDEMA 72 0.0047
724 PRODUCT QUALITY ISSUE 634 0.0047
725 SCRATCH 49 0.0046
726 HEAD DISCOMFORT 82 0.0046
727 PULMONARY ARTERIAL HYPERTENSION 67 0.0046
728 IMPAIRED GASTRIC EMPTYING 63 0.0046
729 HYPOGLYCAEMIA 224 0.0046
730 SINUS DISORDER 91 0.0046
731 CLOSTRIDIUM DIFFICILE INFECTION 100 0.0046
732 THERAPEUTIC RESPONSE SHORTENED 151 0.0045
733 GAMMA-GLUTAMYLTRANSFERASE INCREASED 100 0.0045
734 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 811 0.0045
735 TOOTH EXTRACTION 56 0.0045
736 METABOLIC ACIDOSIS 143 0.0045
737 BRAIN FOG 70 0.0045
738 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 233 0.0045
739 GOUT 80 0.0045
740 CARDIAC FAILURE 354 0.0044
741 ANGINA PECTORIS 126 0.0044
742 ERYTHEMA 903 0.0044
743 ASPIRATION 48 0.0044
744 CAESAREAN SECTION 51 0.0044
745 LYMPHOCYTE COUNT DECREASED 77 0.0044
746 INFLUENZA LIKE ILLNESS 358 0.0043
747 PRODUCT PRESCRIBING ISSUE 94 0.0043
748 PERIPHERAL COLDNESS 59 0.0043
749 EYE HAEMORRHAGE 57 0.0043
750 INCORRECT PRODUCT ADMINISTRATION DURATION 92 0.0042
751 BLOOD ALKALINE PHOSPHATASE INCREASED 105 0.0042
752 ANAPHYLACTIC SHOCK 109 0.0042
753 RASH ERYTHEMATOUS 202 0.0042
754 GASTRIC ULCER 80 0.0042
755 PARALYSIS 60 0.0042
756 ACUTE HEPATIC FAILURE 57 0.0042
757 BURNING SENSATION 292 0.0042
758 ANAEMIA 794 0.0042
759 NEUTROPENIA 565 0.0042
760 CHILLS 483 0.0041
761 CARDIAC ARREST 340 0.0041
762 INJECTION SITE PRURITUS 275 0.0041
763 POOR QUALITY SLEEP 88 0.0041
764 APHONIA 57 0.0041
765 THERAPEUTIC RESPONSE UNEXPECTED 183 0.0041
766 FRACTURE 77 0.0041
767 HAEMOPTYSIS 113 0.0040
768 DISSEMINATED INTRAVASCULAR COAGULATION 57 0.0040
769 STEVENS-JOHNSON SYNDROME 90 0.0040
770 BRAIN OEDEMA 51 0.0040
771 CHRONIC KIDNEY DISEASE 306 0.0040
772 INJECTION SITE BRUISING 321 0.0040
773 PULMONARY OEDEMA 180 0.0040
774 ASCITES 118 0.0040
775 RENAL DISORDER 186 0.0040
776 INTRAOCULAR PRESSURE INCREASED 51 0.0040
777 HEART RATE IRREGULAR 90 0.0040
778 HIP FRACTURE 127 0.0039
779 SKIN CANCER 85 0.0039
780 PULMONARY CONGESTION 52 0.0039
781 DYSPHONIA 230 0.0039
782 MENTAL STATUS CHANGES 109 0.0039
783 HOSPITALISATION 603 0.0039
784 LOCAL SWELLING 68 0.0039
785 COLITIS 147 0.0039
786 SWELLING FACE 252 0.0039
787 DISEASE PROGRESSION 457 0.0039
788 EJECTION FRACTION DECREASED 60 0.0039
789 BLOOD POTASSIUM DECREASED 116 0.0039
790 HAEMATURIA 132 0.0039
791 THROAT TIGHTNESS 104 0.0038
792 CHOLELITHIASIS 126 0.0038
793 END STAGE RENAL DISEASE 70 0.0038
794 MYALGIA 651 0.0038
795 INSURANCE ISSUE 58 0.0038
796 SURGERY 222 0.0038
797 INTENTIONAL PRODUCT MISUSE 331 0.0038
798 TOOTH LOSS 78 0.0038
799 BLOOD CREATINE PHOSPHOKINASE INCREASED 108 0.0037
800 PRURITUS GENERALISED 81 0.0037
801 SKIN DISCOLOURATION 172 0.0037
802 INFUSION SITE PAIN 48 0.0037
803 BLOOD PRESSURE ABNORMAL 74 0.0037
804 ORTHOSTATIC HYPOTENSION 64 0.0037
805 PARAESTHESIA ORAL 53 0.0037
806 PLATELET COUNT DECREASED 391 0.0037
807 TINNITUS 168 0.0037
808 INCREASED APPETITE 69 0.0036
809 INJECTION SITE HAEMATOMA 52 0.0036
810 RESTLESS LEGS SYNDROME 65 0.0036
811 ARRHYTHMIA 168 0.0035
812 COAGULOPATHY 59 0.0035
813 THROAT IRRITATION 158 0.0035
814 HYPOMAGNESAEMIA 49 0.0035
815 BRONCHOSPASM 50 0.0035
816 DIPLOPIA 91 0.0035
817 LIP SWELLING 116 0.0035
818 INJECTION SITE RASH 106 0.0035
819 INJECTION SITE URTICARIA 84 0.0034
820 FEELING JITTERY 65 0.0034
821 GASTRITIS 89 0.0034
822 FEELING ABNORMAL 807 0.0034
823 EYE IRRITATION 193 0.0033
824 EMOTIONAL DISORDER 103 0.0033
825 ACUTE MYOCARDIAL INFARCTION 98 0.0033
826 DEVICE RELATED INFECTION 51 0.0033
827 PALPITATIONS 388 0.0033
828 CARDIAC FAILURE CONGESTIVE 266 0.0033
829 URINARY INCONTINENCE 98 0.0033
830 UNEVALUABLE EVENT 248 0.0033
831 HEMIPARESIS 55 0.0032
832 LETHARGY 185 0.0032
833 ATRIAL FIBRILLATION 312 0.0032
834 INTENTIONAL OVERDOSE 205 0.0032
835 HAEMORRHOIDS 62 0.0032
836 RASH PAPULAR 70 0.0031
837 CRYING 113 0.0031
838 INJECTION SITE SWELLING 237 0.0031
839 PALLOR 84 0.0031
840 CHEST DISCOMFORT 316 0.0031
841 PRESYNCOPE 75 0.0031
842 THERAPY INTERRUPTED 220 0.0031
843 BLINDNESS 124 0.0030
844 HOT FLUSH 229 0.0030
845 PRODUCT COMPLAINT 76 0.0030
846 PROCEDURAL PAIN 83 0.0030
847 INJECTION SITE ERYTHEMA 370 0.0030
848 PANCREATITIS ACUTE 67 0.0030
849 MYOCARDIAL INFARCTION 520 0.0030
850 SYNCOPE 298 0.0030
851 RASH MACULAR 104 0.0030
852 CHOKING 58 0.0030
853 AGEUSIA 74 0.0030
854 PNEUMONIA ASPIRATION 74 0.0030
855 BALANCE DISORDER 255 0.0029
856 EYE PAIN 166 0.0029
857 TUBULOINTERSTITIAL NEPHRITIS 55 0.0029
858 CHROMATURIA 66 0.0029
859 NERVOUS SYSTEM DISORDER 91 0.0029
860 NO ADVERSE EVENT 526 0.0029
861 PRODUCT AVAILABILITY ISSUE 66 0.0029
862 PRODUCT DOSE OMISSION ISSUE 848 0.0029
863 HAEMATOCHEZIA 158 0.0029
864 PRODUCT DOSE OMISSION IN ERROR 80 0.0028
865 OCULAR HYPERAEMIA 134 0.0028
866 INJECTION SITE WARMTH 58 0.0028
867 CIRCULATORY COLLAPSE 48 0.0028
868 HEAD INJURY 89 0.0028
869 HYPERKALAEMIA 98 0.0028
870 FAECES DISCOLOURED 60 0.0028
871 FEELING COLD 77 0.0028
872 BLOOD PRESSURE DECREASED 183 0.0028
873 SOMNOLENCE 552 0.0027
874 BLOOD BILIRUBIN INCREASED 74 0.0027
875 BREAST CANCER 255 0.0027
876 BRADYCARDIA 145 0.0027
877 ACTIVITIES OF DAILY LIVING IMPAIRED 54 0.0027
878 SWOLLEN TONGUE 85 0.0027
879 CARDIOVASCULAR DISORDER 69 0.0027
880 BONE MARROW FAILURE 55 0.0027
881 CEREBRAL INFARCTION 66 0.0027
882 MOOD SWINGS 86 0.0027
883 DEPRESSED MOOD 141 0.0027
884 MYELOSUPPRESSION 96 0.0027
885 DYSURIA 98 0.0027
886 SKIN FISSURES 52 0.0027
887 INJECTION SITE PAIN 814 0.0027
888 OVERDOSE 571 0.0026
889 VERTIGO 161 0.0026
890 SNEEZING 59 0.0026
891 PRODUCT DOSE OMISSION 170 0.0026
892 HEPATIC FUNCTION ABNORMAL 97 0.0026
893 DYSPHAGIA 244 0.0026
894 LACRIMATION INCREASED 77 0.0025
895 EPISTAXIS 189 0.0025
896 NERVOUSNESS 132 0.0025
897 HAEMATOMA 65 0.0025
898 SEROTONIN SYNDROME 48 0.0025
899 ALTERED STATE OF CONSCIOUSNESS 54 0.0025
900 HEPATIC FAILURE 75 0.0025
901 HYPERHIDROSIS 315 0.0024
902 CORONARY ARTERY DISEASE 73 0.0024
903 TRANSIENT ISCHAEMIC ATTACK 81 0.0024
904 INJECTION SITE HAEMORRHAGE 191 0.0024
905 CARDIAC DISORDER 223 0.0024
906 POLLAKIURIA 99 0.0024
907 SPEECH DISORDER 124 0.0024
908 SUICIDAL IDEATION 215 0.0023
909 HYPOACUSIS 100 0.0023
910 HYPONATRAEMIA 130 0.0023
911 URINARY RETENTION 77 0.0023
912 DRUG DEPENDENCE 368 0.0023
913 BONE PAIN 134 0.0023
914 COMPLETED SUICIDE 190 0.0023
915 VISION BLURRED 313 0.0023
916 HYPERGLYCAEMIA 81 0.0022
917 APHASIA 67 0.0022
918 SKIN EXFOLIATION 187 0.0022
919 INTESTINAL OBSTRUCTION 83 0.0022
920 SEIZURE 251 0.0022
921 ABDOMINAL PAIN LOWER 54 0.0021
922 EXPOSURE VIA SKIN CONTACT 55 0.0021
923 EYE SWELLING 78 0.0021
924 LUNG NEOPLASM MALIGNANT 86 0.0021
925 TREMOR 347 0.0021
926 FLUSHING 210 0.0021
927 CONSTIPATION 450 0.0021
928 RENAL INJURY 61 0.0021
929 PANIC ATTACK 74 0.0020
930 DYSARTHRIA 75 0.0020
931 FLATULENCE 112 0.0020
932 GASTROINTESTINAL HAEMORRHAGE 165 0.0020
933 HAEMORRHAGE 206 0.0020
934 PAIN OF SKIN 53 0.0020
935 CARDIO-RESPIRATORY ARREST 82 0.0020
936 VISUAL ACUITY REDUCED 65 0.0020
937 HYPERSOMNIA 56 0.0020
938 DEHYDRATION 258 0.0019
939 DEVICE MALFUNCTION 133 0.0019
940 COGNITIVE DISORDER 88 0.0019
941 ECZEMA 98 0.0019
942 ACCIDENTAL OVERDOSE 68 0.0019
943 RASH GENERALISED 48 0.0019
944 ACNE 140 0.0018
945 DYSGEUSIA 136 0.0018
946 JAUNDICE 49 0.0018
947 EYE PRURITUS 60 0.0018
948 NEUTROPHIL COUNT DECREASED 72 0.0018
949 CEREBROVASCULAR ACCIDENT 294 0.0017
950 DEVICE ISSUE 155 0.0017
951 NEEDLE ISSUE 50 0.0017
952 SUICIDE ATTEMPT 103 0.0017
953 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 79 0.0017
954 INTERNATIONAL NORMALISED RATIO INCREASED 48 0.0017
955 MENTAL DISORDER 73 0.0017
956 FEBRILE NEUTROPENIA 111 0.0017
957 DEPRESSED LEVEL OF CONSCIOUSNESS 66 0.0017
958 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 56 0.0017
959 INCORRECT DOSE ADMINISTERED 374 0.0016
960 NIGHTMARE 56 0.0016
961 THERAPY CESSATION 82 0.0016
962 VAGINAL HAEMORRHAGE 67 0.0015
963 PRODUCT SUBSTITUTION ISSUE 86 0.0015
964 CEREBRAL HAEMORRHAGE 53 0.0015
965 WRONG TECHNIQUE IN DRUG USAGE PROCESS 53 0.0015
966 DRY SKIN 188 0.0014
967 AGITATION 102 0.0014
968 RHABDOMYOLYSIS 56 0.0013
969 DISORIENTATION 52 0.0013
970 INJECTION SITE MASS 48 0.0013
971 DEATH 1109 0.0013
972 DISTURBANCE IN ATTENTION 69 0.0013
973 MULTIPLE SCLEROSIS 61 0.0013
974 DRUG DOSE OMISSION 210 0.0013
975 ACCIDENTAL EXPOSURE TO PRODUCT 130 0.0013
976 PRODUCT STORAGE ERROR 109 0.0012
977 COMA 59 0.0012
978 AGGRESSION 62 0.0012
979 HALLUCINATION 92 0.0012
980 BLOOD GLUCOSE INCREASED 226 0.0012
981 DEVICE LEAKAGE 52 0.0012
982 DRUG ABUSE 99 0.0012
983 IRRITABILITY 70 0.0012
984 PROSTATE CANCER 88 0.0011
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 75 0.0011
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 199 0.0010
987 EMOTIONAL DISTRESS 108 0.0009
988 DEVICE DIFFICULT TO USE 56 0.0008
989 SKIN BURNING SENSATION 55 0.0008
990 MALIGNANT NEOPLASM PROGRESSION 49 0.0005